Cyfuse Biomedical K.K. (4892.T)

JPY 985.0

(0.2%)

Long Term Debt Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual long term debt in 2023 was 345 Million JPY , down -4.96% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly long term debt in 2024 Q1 was 340.5 Million JPY , down -1.3% from previous quarter.
  • Cyfuse Biomedical K.K. reported annual long term debt of 363 Million JPY in 2022, up 0.88% from previous year.
  • Cyfuse Biomedical K.K. reported annual long term debt of 359.82 Million JPY in 2021, down -18.22% from previous year.
  • Cyfuse Biomedical K.K. reported quarterly long term debt of 336 Million JPY for 2024 Q2, down -1.32% from previous quarter.
  • Cyfuse Biomedical K.K. reported quarterly long term debt of 349.5 Million JPY for 2023 Q3, down -1.27% from previous quarter.

Annual Long Term Debt Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Long Term Debt of Cyfuse Biomedical K.K. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 345 Million JPY -4.96%
2022 363 Million JPY 0.88%
2021 359.82 Million JPY -18.22%
2020 439.98 Million JPY 0.0%

Peer Long Term Debt Comparison of Cyfuse Biomedical K.K.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 71.974%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.992%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.741%
Shionogi & Co., Ltd. 8.75 Billion JPY 96.058%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 70.052%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.744%
Morishita Jintan Co., Ltd. 106 Million JPY -225.472%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -353.947%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 95.086%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 97.415%
Tsumura & Co. 54.37 Billion JPY 99.366%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -1468.182%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.818%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 97.107%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 95.657%
KYORIN Holdings, Inc. 435 Million JPY 20.69%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 87.413%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 92.611%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -1177.778%
Modalis Therapeutics Corporation 412.5 Million JPY 16.364%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 92.342%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 99.484%
Toho Holdings Co., Ltd. 28.16 Billion JPY 98.775%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 78.321%